Latest article
The High Cost of Raw Materials and Affiliate Profits Drag Down Vietnam’s Pharma Industry
In the first quarter of 2025, Vietnam Pharmaceutical Corporation - Joint Stock Company (UPCoM: DVN) experienced a decline in profits due to a variety of factors.
The Rising Cost of Raw Materials: Traphaco’s First Quarter Setback
For the first quarter of 2025, JSC Traphaco (HOSE: TRA) experienced a regressive business period, primarily due to elevated cost of goods sold.
Is FECON’s 200 Billion Profit Goal at Risk Due to Consecutive Losses in the...
FECON Corporation (HOSE: FCN) reported a 34% increase in revenue for the first quarter of 2025, however, the company still incurred a loss of VND 7 billion, marking the second consecutive quarter of losses as financial expenses continue to weigh heavily. This puts the company's target of VND 200 billion in profits for the year at a more challenging position.
